These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 23201725)
1. Lyophilized wafers comprising carrageenan and pluronic acid for buccal drug delivery using model soluble and insoluble drugs. Kianfar F; Antonijevic M; Chowdhry B; Boateng JS Colloids Surf B Biointerfaces; 2013 Mar; 103():99-106. PubMed ID: 23201725 [TBL] [Abstract][Full Text] [Related]
2. Development and physico-mechanical characterization of carrageenan and poloxamer-based lyophilized matrix as a potential buccal drug delivery system. Kianfar F; Ayensu I; Boateng JS Drug Dev Ind Pharm; 2014 Mar; 40(3):361-9. PubMed ID: 23600651 [TBL] [Abstract][Full Text] [Related]
3. Novel films for drug delivery via the buccal mucosa using model soluble and insoluble drugs. Kianfar F; Chowdhry BZ; Antonijevic MD; Boateng JS Drug Dev Ind Pharm; 2012 Oct; 38(10):1207-20. PubMed ID: 22204701 [TBL] [Abstract][Full Text] [Related]
4. Characterisation of freeze-dried wafers and solvent evaporated films as potential drug delivery systems to mucosal surfaces. Boateng JS; Auffret AD; Matthews KH; Humphrey MJ; Stevens HN; Eccleston GM Int J Pharm; 2010 Apr; 389(1-2):24-31. PubMed ID: 20083177 [TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of laminated thiolated chitosan-based freeze-dried wafers for potential buccal delivery of macromolecules. Boateng JS; Ayensu I Drug Dev Ind Pharm; 2014 May; 40(5):611-8. PubMed ID: 24506457 [TBL] [Abstract][Full Text] [Related]
6. Development and functional characterization of composite freeze dried wafers for potential delivery of low dose aspirin for elderly people with dysphagia. Farias S; Boateng JS Int J Pharm; 2018 Dec; 553(1-2):65-83. PubMed ID: 30312748 [TBL] [Abstract][Full Text] [Related]
7. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part I: formulation, manufacturing and characterization. Albertini B; Passerini N; Di Sabatino M; Monti D; Burgalassi S; Chetoni P; Rodriguez L Int J Pharm; 2010 Oct; 399(1-2):71-9. PubMed ID: 20696227 [TBL] [Abstract][Full Text] [Related]
8. Development and physico-mechanical characterisation of lyophilised chitosan wafers as potential protein drug delivery systems via the buccal mucosa. Ayensu I; Mitchell JC; Boateng JS Colloids Surf B Biointerfaces; 2012 Mar; 91():258-65. PubMed ID: 22130527 [TBL] [Abstract][Full Text] [Related]
9. Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen. Djekic L; Krajisnik D; Martinovic M; Djordjevic D; Primorac M Int J Pharm; 2015 Jul; 490(1-2):180-9. PubMed ID: 26002567 [TBL] [Abstract][Full Text] [Related]
10. In vitro drug release studies of polymeric freeze-dried wafers and solvent-cast films using paracetamol as a model soluble drug. Boateng JS; Matthews KH; Auffret AD; Humphrey MJ; Stevens HN; Eccleston GM Int J Pharm; 2009 Aug; 378(1-2):66-72. PubMed ID: 19477255 [TBL] [Abstract][Full Text] [Related]
11. Pluronic lecithin organogel as a topical drug delivery system. Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074 [TBL] [Abstract][Full Text] [Related]
12. Nanosizing of a drug/carrageenan complex to increase solubility and dissolution rate. Dai WG; Dong LC; Song YQ Int J Pharm; 2007 Sep; 342(1-2):201-7. PubMed ID: 17560055 [TBL] [Abstract][Full Text] [Related]
13. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552 [TBL] [Abstract][Full Text] [Related]
14. Coprocessing via spray drying as a formulation platform to improve the compactability of various drugs. Gonnissen Y; Verhoeven E; Peeters E; Remon JP; Vervaet C Eur J Pharm Biopharm; 2008 May; 69(1):320-34. PubMed ID: 18248803 [TBL] [Abstract][Full Text] [Related]
15. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers. Dhumal RS; Shimpi SL; Paradkar AR Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109 [TBL] [Abstract][Full Text] [Related]
16. Development of fully amorphous dispersions of a low T(g) drug via co-spray drying with hydrophilic polymers. Zhao M; Barker SA; Belton PS; McGregor C; Craig DQ Eur J Pharm Biopharm; 2012 Nov; 82(3):572-9. PubMed ID: 22922419 [TBL] [Abstract][Full Text] [Related]
17. Investigation of Carrageenan Aerogel Microparticles as a Potential Drug Carrier. Obaidat RM; Alnaief M; Mashaqbeh H AAPS PharmSciTech; 2018 Jul; 19(5):2226-2236. PubMed ID: 29736886 [TBL] [Abstract][Full Text] [Related]
18. Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettability. Miriyala N; Ouyang D; Perrie Y; Lowry D; Kirby DJ Eur J Pharm Biopharm; 2017 Jun; 115():197-205. PubMed ID: 28284728 [TBL] [Abstract][Full Text] [Related]
19. Formulation, characterisation and stabilisation of buccal films for paediatric drug delivery of omeprazole. Khan S; Boateng JS; Mitchell J; Trivedi V AAPS PharmSciTech; 2015 Aug; 16(4):800-10. PubMed ID: 25559373 [TBL] [Abstract][Full Text] [Related]
20. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407. Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]